Literature DB >> 12973937

Effect and mechanism of superantigen staphylococcal enterotoxin therapy for mouse gastric tumor.

Yiqing Li1, Xiaogang Shu.   

Abstract

The anti-tumor effect and mechanism of the staphylococcal enterotoxin A (SEA) were studied. The mouse gastric tumor model was produced by subcutaneously inoculating gastric tumor cells (MGC80-3). The experimental group was treated with SEA, and the control group was treated with normal saline. The percentage of tumor generation and tumor mass was measured. The results showed that the percentage of the tumor generation in the SEA-treated mice was lower than in the control group, but there was no significant difference (P > 0.05). However, the tumor mass in the experimental group was significantly lighter than in the control group, with the difference being very significant (P < 0.001). There were more CD4+ T cells and CD8+ T cells in the tumor of the mice treated with SEA than those of the control group. SEA has an obvious anti-tumor effect on mice gastric tumor. The mechanism might be that SEA induces the effect of superantigen-dependent cell mediated cytotoxicity to the tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12973937     DOI: 10.1007/BF02859944

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  4 in total

1.  Activation-induced cell death in human T cells is a suicidal process regulated by cell density but superantigen induces T cell fratricide.

Authors:  Patricia Gorak-Stolinska; David M Kemeny; Alistair Noble
Journal:  Cell Immunol       Date:  2002-10       Impact factor: 4.868

2.  Simultaneous cytometric analysis of (auto)antigen-reactive T and B cell proliferation.

Authors:  Sandra Schneider; Anne Bruns; Beate Moewes; Barbara Holzknecht; Gerd Hausdorf; Gabriela Riemekasten; Andreas Radbruch; Falk Hiepe; Andreas Thiel
Journal:  Immunobiology       Date:  2002-12       Impact factor: 3.144

3.  Superantigen-induced human CD4+ helper/killer T cell phenomenon. Selective induction of Th1 helper/killer T cells and application to tumor immunotherapy.

Authors:  S Kuge; Y Miura; Y Nakamura; T Mitomi; S Habu; T Nishimura
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

4.  Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells.

Authors:  G Hedlund; M Dohlsten; C Petersson; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.